Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Leiper

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Journal of the American Society of Nephrology : JASN|July 1, 2005
Asymmetric dimethylarginine and kidney disease--marker or mediator?Patrick Vallance, James Leiper
Arteriosclerosis, Thrombosis, and Vascular Biology|March 31, 2012
Endogenous nitric oxide synthase inhibitors in the biology of disease: markers, mediators, and regulators?Ben Caplin, James Leiper
Arteriosclerosis, Thrombosis, and Vascular Biology|April 24, 2004
Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathwayPatrick Vallance, James Leiper
Nature Reviews. Drug Discovery|December 4, 2002
Blocking NO synthesis: how, where and why?Patrick Vallance, James Leiper
Arteriosclerosis, Thrombosis, and Vascular Biology|June 24, 2006
New tricks from an old dog: nitric oxide-independent effects of dimethylarginine dimethylaminohydrolaseJames Leiper, Patrick Vallance
Nature Reviews. Drug Discovery|April 2, 2011
The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesisJames Leiper, Manasi Nandi
Methods in Enzymology|April 1, 2008
Rho GTPases and hypoxia in pulmonary vascular endothelial cellsBeata Wojciak-Stothard, James Leiper
Vascular Medicine (London, England)|February 1, 2006
Endogenous production of nitric oxide synthase inhibitorsShelagh Anthony, James Leiper, Patrick Vallance
Vascular Medicine (London, England)|March 29, 2008
Over-expression of GTP-cyclohydrolase 1 feedback regulatory protein attenuates LPS and cytokine-stimulated nitric oxide productionManasi Nandi, Peter Kelly, Patrick Vallance, et al.
European Heart Journal|June 5, 2026
British Heart Foundation Data Science Centre 2.0: faster, fairer cardiovascular data-driven discoverySteffen E Petersen, Rhoswyn A Walker, James Leiper
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Journal of the American Society of Nephrology : JASN|July 1, 2005
Asymmetric dimethylarginine and kidney disease--marker or mediator?Patrick Vallance, James Leiper
Arteriosclerosis, Thrombosis, and Vascular Biology|March 31, 2012
Endogenous nitric oxide synthase inhibitors in the biology of disease: markers, mediators, and regulators?Ben Caplin, James Leiper
Arteriosclerosis, Thrombosis, and Vascular Biology|April 24, 2004
Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathwayPatrick Vallance, James Leiper
Nature Reviews. Drug Discovery|December 4, 2002
Blocking NO synthesis: how, where and why?Patrick Vallance, James Leiper
Arteriosclerosis, Thrombosis, and Vascular Biology|June 24, 2006
New tricks from an old dog: nitric oxide-independent effects of dimethylarginine dimethylaminohydrolaseJames Leiper, Patrick Vallance
Nature Reviews. Drug Discovery|April 2, 2011
The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesisJames Leiper, Manasi Nandi
Methods in Enzymology|April 1, 2008
Rho GTPases and hypoxia in pulmonary vascular endothelial cellsBeata Wojciak-Stothard, James Leiper
Vascular Medicine (London, England)|February 1, 2006
Endogenous production of nitric oxide synthase inhibitorsShelagh Anthony, James Leiper, Patrick Vallance
Vascular Medicine (London, England)|March 29, 2008
Over-expression of GTP-cyclohydrolase 1 feedback regulatory protein attenuates LPS and cytokine-stimulated nitric oxide productionManasi Nandi, Peter Kelly, Patrick Vallance, et al.
European Heart Journal|June 5, 2026
British Heart Foundation Data Science Centre 2.0: faster, fairer cardiovascular data-driven discoverySteffen E Petersen, Rhoswyn A Walker, James Leiper
Pageof 6